GRCE

Grace Therapeutics
GRCE

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $2.29M invested in Grace Therapeutics in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.48M
2
+$229K
3
+$157K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$77.5K
5
Citadel Advisors
Citadel Advisors
Florida
+$50K

Top Sellers

1
-$81K
2
-$79K
3
-$10K
4
Morgan Stanley
Morgan Stanley
New York
-$1.74K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.48M
2
$229K
3
$206K
4
$157K
5
$50K
6
$40K
7
$32K
8
$31K
9
$31K
10
$28K
11
$3K
12
$25
13
–
14
–